Decheng Capital China Life Sciences USD Fund III, L.P. files SEC Form 4 reports at BeyondSpring Inc. (BYSI). 17 SEC Form 4 filings on record, most recently on 20 October 2025. Most recent open-market trade: sold $80K of BYSI on 20 October 2025. Lifetime open-market sales: $2.02M.
Recent transactions
20
The latest 20 SEC Form 4 transactions reported by Decheng Capital China Life Sciences USD Fund III, L.P..
InsiderAlpha's records for Decheng Capital China Life Sciences USD Fund III, L.P. go back to 2025: 17 primary Form 4 filings, an average of 8.5 per year. No recorded transaction carries a Rule 10b5-1 plan flag. An absent flag does not establish whether a transaction was pre-arranged or discretionary.
Other insiders active in the same sector
No other insider has filed at Decheng Capital China Life Sciences USD Fund III, L.P.'s companies, so these are insiders reporting open-market trades at other companies in the same sector.
Amirali Talasaz - $73.75M in GH purchases and sales in the last 12 months
L1 Capital Pty Ltd - $72.66M in AVR purchases and sales in the last 12 months
James E. Flynn - $70.87M in NUVL purchases and sales in the last 12 months
Joaquin Duato - $66.84M in JNJ purchases and sales in the last 12 months
EcoR1 Capital, LLC - $65.00M in TRAX purchases and sales in the last 12 months
What is Decheng Capital China Life Sciences USD Fund III, L.P.?
Decheng Capital China Life Sciences USD Fund III, L.P. is an investment firm of BeyondSpring Inc. (BYSI). InsiderAlpha holds 17 primary Form 4 filings for it, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Decheng Capital China Life Sciences USD Fund III, L.P. last file a Form 4?
The most recent primary Form 4 on record is dated 20 October 2025, one of 17 filings going back to 2025.
Has Decheng Capital China Life Sciences USD Fund III, L.P. been buying or selling stock?
Recorded transactions: 0 open-market purchases and 63 open-market sales ($2.02M) across all tracked filings.
